top of page
  • Linda Salamin

Hope and Insights from the 36th Global Conference of Alzheimer's Disease International

Alzheimer's Disease International ADI is the international federation of 105 Alzheimer associations and federations around the world, in official relations with the World Health Organization WHO. ADI hosted a global conference that took place in Krakow, Poland on Aprl 24 - 26.


Scope

The scope of the conference spanned scientific and non-scientific content and aimed to include all stakeholders from medical professionals and researchers to caregivers and people living with dementia.


The main themes of the conference were divided into the 7 key areas of the WHO Global action plan on dementia:

  • public health

  • awareness and friendliness

  • support for caregivers

  • diagnosis

  • treatement and care

  • risk reduction

  • information systems

Research and innovation were a part of the key topics.


New research areas:

  • biomarkers

  • dementia therapies (music, art, dance, etc.)

  • assisted technology - AI and innovation

  • less common dementias and syndromes (including Down Syndrome and childhood dementia)

  • LGBTQ+ and dementia


These topics were presented by a broad range of prestigious, internaitonal experts in panel discussions, presentations, and workshops to put forth new advances in trials, therapies and approaches designed to slow progression of dementia. A special highlight: along with the experts, people living with Alzheimer's spoke of how they were diagnosed and their lives today.


What's next?

Promising new drugs currently in clinical trials are showing possibility of arresting and reducing disease progression.

Research in amyloid antibodies for use in prevention and therapies are in clinical trials.

The use of AI:

  • novel approach to detecting DNA - anlysing blood markers

  • can accellerate detection through advanced identity of subtle cognitive decline

  • can support caregivers through digital support in the home

Finally, collaborating with people living with dementia to create new and practical solutions was emphasized.


There are 55 million  people living with dementia globally, set to triple to over 150 million by 2050. This ADI Global Conference has shown promising research in detection, treatment and care with many more therapies currently in the pipeline.


For further information about the work of ADI, visit the website: https://www.alzint.org/



Comments


bottom of page